Search for: "MYLAN LABORATORIES LIMITED"
Results 81 - 94
of 94
Sorted by Relevance
|
Sort by Date
27 Jun 2008, 10:04 am
Porsche AG: (Class 46), WIPO: Yell Limited v Yell.travel: domain name yell.travel to be transferred to Yell Limited: (Class 46), Some see rise in non-traditional trade marks; national registries not yet: (Intellectual Property Watch) Global - Patents Lower patentability standards – strategic responses: (IP Thinktank), IP Business Congress sees Finnish inventor become a millionaire: (IAM), Ron Slusky: Five prescriptions for effectively analysing an invention and… [read post]
26 Jun 2008, 6:31 pm
., Mylan Laboratories, Inc., v. [read post]
7 Nov 2014, 5:52 am
Law Div. 2005).Heeding presumptions are something that exists in some states (Massachusetts, Missouri, Oklahoma), doesn’t in others (California, Connecticut, Alabama), and is limited in still others (New, Jersey, Pennsylvania, Texas). [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
19 Sep 2008, 6:00 pm
: (Techdirt), (Techdirt), Pharma & Biotech Pharma & Biotech - General Biotech patent law: eleven key pending cases and future developments to watch: (Hal Wegner), (PatentDocs) Study by The Innovation Group highlights damaging intellectual property has been to biotech: (Techdirt), Drug regulatory agencies collaborate on counterfeits, new medical products: (Intellectual Property Watch), Canada: Health Canada releases summary report on industry consultations regarding… [read post]
23 Sep 2010, 11:56 am
Mylan, Inc., slip op., 2010 U.S. [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) – Lundbeck wins… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
24 Jun 2011, 3:25 pm
Certiorari stage documents:Opinion below (6th Circuit) Petition for certiorari Brief in opposition CVSG Information:Invited: February 28, 2011Filed: May 26, 2011 (Deny) Title: Caraco Pharmaceutical Laboratories, Ltd. v. [read post]
18 Jul 2014, 11:55 am
This post is only from the Reed Smith (more properly, the non-Dechert) side of the blog.One hundred what, you say? [read post]
28 Mar 2008, 6:00 am
: (Patent Docs),US: Alnylam CEO forecasts ‘perfect storm’ for biomedical patents: (Patent Docs),US: Human Genome launches patent suit against Genentech over type of protein used to detect tumours: (IP Law360)Pharma & Biotech - ProductsCaduet (Atorvastatin/Amlodipine) – US: Pfizer sues Ranbaxy to block generic Caduet until 2016: (IP Law360),Dovonex (Calcipotriol) – Chancery Division EWHC grants interim injunction prohibiting Sandoz from distributing… [read post]
